Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad Tang

Showing results (121-130 of 221) with videos related to

Pageof 23
Sort By:
Nature Biotechnology|August 16, 2011
An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cellsChad Tang, Andrew S Lee, Jens-Peter Volkmer, et al.
Communications Medicine|May 25, 2024
Plasmonic nano-aperture label-free imaging of single small extracellular vesicles for cancer detectionNareg Ohannesian, Mohammad Sadman Mallick, Jianzhong He, et al.
Journal of Applied Clinical Medical Physics|April 20, 2026
Quantifying setup uncertainty between computed tomography guidance and magnetic resonance guidance in intramuscular metastases radiotherapyTravis Salzillo, Surendra Prajapati, Zhiqian Henry Yu, et al.
Prostate Cancer and Prostatic Diseases|October 11, 2025
Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancerXiaolei Shi, Jarey H Wang, Brian F Chapin, et al.
Communications Medicine|June 28, 2024
Author Correction: Plasmonic nano-aperture label-free imaging of single small extracellular vesicles for cancer detectionNareg Ohannesian, Mohammad Sadman Mallick, Jianzhong He, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2025
Hypofractionated, Dose-Escalated Radiation Versus Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase III, Prospective, Randomized Controlled TrialComron Hassanzadeh, Deborah Kuban, Sarah Pasyar, et al.
Seminars in Radiation Oncology|June 6, 2021
Considerations for Clinical Trials Testing Radiotherapy Combined With Immunotherapy for Metastatic DiseaseDuygu Sezen, Vivek Verma, Kewen He, et al.
Cancer Immunology Research|September 5, 2014
Combining radiation and immunotherapy: a new systemic therapy for solid tumors?Chad Tang, Xiaohong Wang, Hendrick Soh, et al.
JCO Oncology Practice|November 26, 2019
Time-Driven, Activity-Based Cost Analysis of Radiation Treatment Options for Spinal MetastasesDavid Boyce-Fappiano, Matthew S Ning, Nikhil G Thaker, et al.
Clinical and Translational Radiation Oncology|June 13, 2020
Evaluating single-institution resource costs of consolidative radiotherapy for oligometastatic non-small cell lung cancer using time-driven activity-based costingTodd A Pezzi, Matthew S Ning, Nikhil G Thaker, et al.
Pageof 23

Showing results (121-130 of 221) with videos related to

Sort By:
Pageof 23
Nature Biotechnology|August 16, 2011
An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cellsChad Tang, Andrew S Lee, Jens-Peter Volkmer, et al.
Communications Medicine|May 25, 2024
Plasmonic nano-aperture label-free imaging of single small extracellular vesicles for cancer detectionNareg Ohannesian, Mohammad Sadman Mallick, Jianzhong He, et al.
Journal of Applied Clinical Medical Physics|April 20, 2026
Quantifying setup uncertainty between computed tomography guidance and magnetic resonance guidance in intramuscular metastases radiotherapyTravis Salzillo, Surendra Prajapati, Zhiqian Henry Yu, et al.
Prostate Cancer and Prostatic Diseases|October 11, 2025
Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancerXiaolei Shi, Jarey H Wang, Brian F Chapin, et al.
Communications Medicine|June 28, 2024
Author Correction: Plasmonic nano-aperture label-free imaging of single small extracellular vesicles for cancer detectionNareg Ohannesian, Mohammad Sadman Mallick, Jianzhong He, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2025
Hypofractionated, Dose-Escalated Radiation Versus Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase III, Prospective, Randomized Controlled TrialComron Hassanzadeh, Deborah Kuban, Sarah Pasyar, et al.
Seminars in Radiation Oncology|June 6, 2021
Considerations for Clinical Trials Testing Radiotherapy Combined With Immunotherapy for Metastatic DiseaseDuygu Sezen, Vivek Verma, Kewen He, et al.
Cancer Immunology Research|September 5, 2014
Combining radiation and immunotherapy: a new systemic therapy for solid tumors?Chad Tang, Xiaohong Wang, Hendrick Soh, et al.
JCO Oncology Practice|November 26, 2019
Time-Driven, Activity-Based Cost Analysis of Radiation Treatment Options for Spinal MetastasesDavid Boyce-Fappiano, Matthew S Ning, Nikhil G Thaker, et al.
Clinical and Translational Radiation Oncology|June 13, 2020
Evaluating single-institution resource costs of consolidative radiotherapy for oligometastatic non-small cell lung cancer using time-driven activity-based costingTodd A Pezzi, Matthew S Ning, Nikhil G Thaker, et al.
Pageof 23